T1	Condition 38 61	vulvar lichen sclerosus
T2	Condition-Name 38 61	vulvar lichen sclerosus
E1	Condition:T1 Name:T2
T3	Condition 270 287	Malignant disease
T4	Condition-Name 270 287	Malignant disease
E3	Condition:T3 Name:T4
T5	Procedure 502 511	treatment
E5	Procedure:T5 
T7	Condition 355 364	infection
T8	Condition-Name 355 364	infection
E7	Condition:T7 Name:T8 Severity:T51
T9	Procedure 467 482	laser treatment
T10	Procedure-Name 467 482	laser treatment
E9	Procedure:T9 Name:T10
T13	Observation 329 332	BMI
T14	Observation-Name 329 332	BMI
E13	Observation:T13 Name:T14 Eq-Comparison:E16
A1	Observation-Type-Value T14 vital
T15	Eq-Operator 85 86	≥
A2	Eq-Operator-Value T15 GTEQ
T16	Eq-Operator 212 213	<
A3	Eq-Operator-Value T16 LT
T17	Eq-Operator 333 334	>
A4	Eq-Operator-Value T17 GT
T18	Eq-Temporal-Unit 216 222	months
A5	Eq-Temporal-Unit-Value T18 month
T19	Eq-Unit 338 340	kg
T20	Eq-Value 87 88	4
T21	Eq-Value 214 215	3
T22	Eq-Value 335 337	35
T23	Eq-Comparison 85 88	≥ 4
E14	Eq-Comparison:T23 Operator:T15 Value:T20
T24	Eq-Comparison 212 222	< 3 months
E15	Eq-Comparison:T24 Operator:T16 Temporal-Unit:T18 Value:T21
T25	Eq-Comparison 333 343	> 35 kg/m²
E16	Eq-Comparison:T25 Operator:T17 Unit:T19 Value:T22 Per:T50
T26	Observation 76 84	LS score
E2	Observation:T26 Name:T27 Eq-Comparison:E14
T27	Observation-Name 76 84	LS score
T28	Modifier 114 125	Concomitant
E4	Modifier:T28 Modifies:T30
T29	Drug 126 133	steroid
E6	Drug:T29 Name:T30
T30	Drug-Name 126 133	steroid
T31	Drug 135 156	calcineurin inhibitor
E8	Drug:T31 Name:T32
T32	Drug-Name 135 156	calcineurin inhibitor
T33	Procedure 190 199	treatment
E10	Procedure:T33 
T34	Modifier 170 177	topical
E12	Modifier:T34 
T35	Modifier 181 189	systemic
E17	Modifier:T35 
T36	Or 178 180	or
E18	Or:T36 Arg:E12 Arg2:E17
A6	Observation-Type-Value T27 clinical-score
T37	Condition 204 206	LS
E19	Condition:T37 Name:T38
T38	Condition-Name 204 206	LS
R1	Treatment-For Arg1:E10 Arg2:E19	
T39	Or 157 159	or
E20	Or:T39 Arg:E8 Arg2:E21
T40	Other 164 169	other
E21	Other:T40 Is-Other:E10
T41	Eq-Comparison 229 234	start
E22	Eq-Comparison:T41 Temporal-Recency:T42
T42	Eq-Temporal-Recency 229 234	start
A7	Eq-Temporal-Recency-Value T42 first-time
T43	Temporal-Connection 223 228	since
E23	Temporal-Connection:T43 Arg:E15 Arg2:E22
A8	Temporal-Connection-Type-Value E23 after
T44	Modifier 238 245	vaginal
E24	Modifier:T44 Modifies:T46
T45	Procedure 246 264	estrogen treatment
E25	Procedure:T45 Name:T46 Temporality:E22 Temporality2:E15
T46	Procedure-Name 246 264	estrogen treatment
T47	Condition 308 314	vulval
E26	Condition:T47 Name:T48
T48	Condition-Name 308 314	vulval
T49	Assertion 315 323	symptoms
E27	Assertion:T49 Asserted:E26
A9	Assertion-Type-Value E27 possible
R2	Caused-By Arg1:E26 Arg2:E3	
T50	Eq-Unit 341 343	m²
T51	Severity 349 354	Acute
A10	Severity-Value T51 severe
T52	Modifier 366 372	fungal
E28	Modifier:T52 Modifies:T8
T53	Modifier 374 383	bacterial
E29	Modifier:T53 Modifies:T8
T54	Modifier 385 390	viral
E30	Modifier:T54 Modifies:T8
T55	Modifier 399 404	vulva
E31	Modifier:T55 Modifies:T8
T11	Modifier 406 412	vagina
E11	Modifier:T11 Modifies:T8
T12	Modifier 416 423	bladder
E32	Modifier:T12 Modifies:T8
T56	Or 413 415	or
E33	Or:T56 Arg:E11 Arg2:E32
T57	Contraindication 441 458	contraindications
E34	Contraindication:T57 Contraindicates:E9 Contraindicates2:E5
T6	Drug 486 501	topical steroid
E35	Drug:T6 Name:T58
T58	Drug-Name 486 501	topical steroid
T59	Or 483 485	or
E36	Or:T59 Arg:E9 Arg2:E35
R3	Using Arg1:E5 Arg2:E35	
